Finance

Beta
Lists
CLYYF:OTCMKTS
Celyad Oncology SA
$0.25
0.00%
(0.00) 1D
Apr 23, 1:08:42 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLYYF...
Mkt. cap
12.41M
Volume
0.00
52-wk high
$0.53
52-wk low
$0.15
Shares outstanding
44.76M
No. of employees
5
Mkt. cap
12.41M
Volume
0.00
52-wk high
$0.53
52-wk low
$0.15
Shares outstanding
44.76M
No. of employees
5
News stories
From sources across the web
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Walloon Brabant, Belgium
SectorBiotechnology
Websitecelyad.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.00K
7.00K
3.50K
3.50K
Cost of goods sold
4.00K
4.00K
-
-
Cost of revenue
4.00K
4.00K
-
-
Research and development expenses
1.04M
1.04M
669.00K
669.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
839.50K
839.50K
1.05M
1.05M
Operating expense
1.83M
1.83M
-1.06M
-1.06M
Total operating expenses
1.83M
1.83M
-1.06M
-1.06M
Operating income
-1.83M
-1.83M
1.06M
1.06M
Other non operating income
-500.00
-500.00
1.00K
1.00K
EBT including unusual items
-1.84M
-1.84M
2.25M
2.25M
EBT excluding unusual items
-1.84M
-1.84M
1.05M
1.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-48.50K
-48.50K
-2.78M
-2.78M
Net income
-1.84M
-1.84M
2.25M
2.25M
Net profit margin
-26,250.00%
-26,250.00%
64,357.14%
64,357.14%
Earnings per share
-
-
-
-
Interest and investment income
11.00K
11.00K
-
-
Interest expense
-21.00K
-21.00K
-16.00K
-16.00K
Net interest expenses
-10.00K
-10.00K
-16.00K
-16.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.72M
-1.72M
1.10M
1.07M
Gain or loss from assets sale
-
-
-1.15M
-1.15M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer